CDC: Precancerous cervical lesions on decline in young women
Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV vaccination and changes in detection of these lesions due to updated cervical cancer screening and management recommendations, the Centers for Disease Control and Prevention reported today. Screen-detected, high-grade cervical lesions develop within a few years after infection and have been used to monitor HPV vaccine impact because HPV-associated cancers typically take decades to develop. In 2006, HPV vaccine was licensed and recommended for girls aged 11-12 and for catch-up vaccination through age 26.
Related News Articles
Headline
The American Medical Association Dec. 16 released its latest annual report on health insurance competition, finding that 97% of commercial markets were highly…
Headline
Approximately 950,000 consumers who currently do not have health insurance coverage through the federally facilitated Health Insurance Marketplace have signed…
Headline
The Senate today failed to pass legislation to address health care affordability. The chamber first voted on a Republican-backed bill that failed by a 51-…
Headline
The AHA Dec. 9 expressed support for the Critical Access for Veterans Care Act (S. 1868), legislation that would expand veteran access to critical access…
Headline
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District…
Headline
The Centers for Medicare & Medicaid Services released a bulletin Nov. 18 summarizing provisions from the budget reconciliation bill related to Medicaid and…